Effect of intradiscal methylene blue injection for the chronic discogenic low back pain: One year prospective follow-up study

Annals of Rehabilitation Medicine

Volumn 36, Issue 5, 2012, Pages 657-664

  Kim, Soo Hyun ^a   Ahn, Sang Ho ^a   Cho, Yun Woo ^a   Lee, Dong Gyu ^b  

^a Yeungnam University College of Medicine   (South Korea)

^b Keimyung University   (South Korea)

Author keywords

Discogenic low back pain; Intradiscal methylene blue injection

Indexed keywords

EID: 84872502620     PISSN: 22340645     EISSN: 22340653     Source Type: Journal    
DOI: 10.5535/arm.2012.36.5.657     Document Type: Article

References (40)

1. Andersson GB. Epidemiologic features of chronic low back pain. Lancet 1999; 354: 581-585
2. Schwarzer AC, Aprill CN, Derby R, Fortin J, Kine G, Bogduk N. The prevalence and clinical features of internal disc disruption in patients with chronic low back pain. Spine 1995; 20: 1878-1883
3. Andersson GB. Epidemiology of low back pain. Acta Orthop Scand Suppl 1998; 281: 28-31
4. Peng B, Pang X, Wu Y, Zhao C, Song X. A randomized placebo-controlled trial of intradiscal methylene blue injection for the treatment of chronic discogenic low back pain. Pain 2010; 149: 124-129
5. Ito M, Incorvaia KM, Yu SF, Fredrickson BE, Yuan HA, Rosenbaum AE. Predictive signs of discogenic lumbar pain on magnetic resonance imaging with discography correlation. Spine 1998; 23: 1252-1260
6. Zhou YL, Abdi S. Diagnosis and minimally invasive treatment of lumbar discogenic pain - a review of the literature. Clin J Pain 2006; 22: 468-481
7. Saal JA. Natural history and nonoperative treatment of lumbar disc herniation. Spine 1996; 21: 2S-9S
8. Smith SE, Darden BV, Rhyne AL, Wood KE. Outcome of unoperated discogram positive low back pain. Spine 1995; 20: 1997-2001
9. Peng B, Wu W, Hou S, Li P, Zhang C, Yang Y. The pathogenesis of discogenic low back pain. J Bone Joint Surg Br 2005; 87: 62-67
10. Moneta GB, Videman T, Kaivanto K, Aprill C, Spivey M, Vanharanta H, Sachs BL, Guyer RD, Hochschuler SH, Raschbaum RF, et al. Reported pain during lumbar discography as a function of annular ruptures and disc degeneration. A re-analysis of 833 discograms. Spine 1994; 19: 1968-1974
11. Kallewaard JW, Terheggen MA, Groen GJ, Sluijter ME, Derby R, Kapural L, Mekhail N, van Kleef M. Discogenic low back pain. Pain Pract 2010; 10: 560-579
12. Pauza KJ, Howell S, Dreyfuss P, Peloza JH, Dawson K, Boqduk N. A randomized, placebo-controlled trial of intradiscal electrothermal therapy for the treatment of discogenic low back pain. Spine J 2004; 4: 27-35
13. Singh K, Ledet E, Carl A. Intradiscal therapy: a review of current treatment modalities. Spine 2005; 30: S20- S26
14. Rohof O. Intradiscal pulsed radiofrequency application following provocative discography for the management of degenerative disc disease and concordant pain: a pilot study. Pain Pract 2012; 12: 342-349
15. Freeman BJ, Fraser RD, Cain CM, Hall DJ, Chapple DC. A randomized, double-blind, controlled trial: intradiscal electrothermal therapy versus placebo for the treatment of chronic discogenic low back pain. Spine 2005; 30: 2369-2378
16. Finch PM, Price LM, Drummond PD. Radiofrequency heating of painful annular disruptions: one-year outcomes. J Spinal Disord Tech 2005; 18: 6-13
17. McMillan MR, Patterson PA, Parker V. Percutaneous laser disc decompression for the treatment of discogenic lumbar pain and sciatica: a preliminary report with 3-month follow-up in a general pain clinic population. Photomed Laser Surg 2004; 22: 434-438
18. Skliarenko ET, Tarabanova LV, Pashkov EP. Cryotherapy of pain syndromes associated with degenerativedystrophic diseases of the spine. Ortop Travmatol Protez 1986; 10: 28-31
19. Lee SH, Derby R, Sul D, Hong J, Kim GH, Kang S, Kim NH, Yoo SH, Lee SJ, Hong YK, et al. Efficacy of a new navigable percutaneous disc decompression device (L'DISQ) in patients with herniated nucleus pulposus related to radicular pain. Pain Med 2011; 12: 370-376
20. Wainwright M, Crossley KB. Methylene blue - a therapeutic dye for all seasons? J Chemother 2002; 14: 431- 443
21. Cetin M, Duran B, Demirkoprulu N, Guvenal T, Erden O, Cetin A. Effects of diazeniumdiolates (NONOates) and methylene blue on the reduction of postoperative adhesion in rats. Gynecol Obstet Invest 2004; 57: 186-190
22. Heydrick SJ, Reed KL, Cohen PA, Aarons CB, Gower AC, Becker JM, Stucchi AF. Intraperitoneal administration of methylene blue attenuates oxidative stress, increases peritoneal fibrinolysis, and inhibits intraabdominal adhesion formation. J Surg Res 2007; 143: 311-319
23. Farouk R, Lee PW. Intradermal methylene blue injection for the treatment of intractable idiopathic pruritus ani. Br J Surg 1997; 84: 670
24. Mentes BB, Akin M, Leventoglu S, Gultekin FA, Oguz M. Intradermal methylene blue injection for the treatment of intractable idiopathic pruritus ani: results of 30 cases. Tech Coloproctol 2004; 8: 11-14
25. Farrokhi MR, Vasei M, Fareghbal S, Farrokhi N. The effect of methylene blue on peridural fibrosis formation after laminectomy in rats: an experimental novel study. Spine J 2011; 11: 147-152
26. National Toxicology Program. Toxicology and carcinogenesis studies of methylene blue trihydrate (Cas No. 7220-79-3) in F344/N rats and B6C3F1 mice (gavage studies). Natl Toxicol Program Tech Rep Ser 2008; 540: 1-224
27. Salman AE, Salman MA, Saricaoglu F, Akinci SB, Aypar Ü. Pain on injection of propofol: a comparison of methylene blue and lidocaine. J Clin Anesth 2011; 23: 270-274
28. Mayer B, Brunner F, Schmidt K. Inhibition of nitric oxide synthesis by methylene blue. Biochem Pharmacol 1993; 45: 367-374
29. Poveda L, Hottiger M, Boos N, Wuertz K. Peroxynitrite induces gene expression in intervertebral disc cells. Spine 2009; 34: 1127-1133
30. Liu GZ, Ishihara H, Osada R, Kimura T, Tsuji H. Nitric oxide mediates the change of proteoglycan synthesis in the human lumbar intervertebral disc in response to hydrostatic pressure. Spine 2001; 26: 134-141
31. Peng B, Zhang Y, Hou S, Wu W, Fu X. Intradiscal methylene blue injection for the treatment of chronic discogenic low back pain. Eur Spine J 2007; 16: 33-38
32. Kang JD, Stefanovic-Racic M, McIntyre LA, Georgescu HI, Evans CH. Toward a biochemical understanding of human intervertebral disc degeneration and herniation. Contributions of nitric oxide, interleukins, prostaglandin E2, and matrix metalloproteinases. Spine 1997; 22: 1065-1073
33. Farrar JT, Portenoy RK, Berlin JA, Kinman JL, Strom BL. Defining the clinically important difference in pain outcome measures. Pain 2000; 88: 287-294
34. Hägg O, Fritzell P, Nordwall A. The clinical importance of changes in outcome scores after treatment for chronic low back pain. Eur Spine J 2003; 12: 12-20
35. Buttermann GR. The effect of spinal steroid injections for degenerative disc disease. Spine J 2004; 4: 495-505
36. Khot A, Bowditch M, Powell J, Sharp D. The use of in tradiscal steroid therapy for lumbar spinal discogenic pain: a randomized controlled trial. Spine 2004; 29: 833-837
37. Miller MR, Mathews RS, Reeves KD. Treatment of painful advanced internal lumbar disc derangement with intradiscal injection of hypertonic dextrose. Pain Physician 2006; 9: 115-121
38. Poppers PJ, Mastri AR, Lebeaux M, Covino BG. The effect of methylene blue on neural tissue. Anesthesiology 1970; 33: 335-340
39. Gross SW. Letter: neurological deficits resulting from intrathecal administration of methylene blue. Neuroradiology 1974; 7: 117
40. Sharr MM, Weller RO, Brice JG. Spinal cord necrosis after intrathecal injection of methylene blue. J Neurol Neurosurg Psychiatry 1978; 41: 384-386